Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:chemical_compound
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Claritin-D_12_Hour
gptkb:Claritin-D |
gptkbp:appointed_by |
oral route
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:contraindication |
gptkb:sneaker
hypertension hyperthyroidism severe coronary artery disease |
gptkbp:developed_by |
ephedrine
|
https://www.w3.org/2000/01/rdf-schema#label |
Pseudoephedrine sulfate
|
gptkbp:ingredients |
C10 H13 N O4 S
|
gptkbp:is_analyzed_in |
clinical trials
pharmacology studies drug interaction studies nasal congestion studies |
gptkbp:is_associated_with |
methamphetamine production
|
gptkbp:is_available_in |
liquid form
tablet form extended-release form |
gptkbp:is_available_on |
gptkb:drug
|
gptkbp:is_known_for |
decreasing nasal swelling
improving airflow through nasal passages opening nasal airways reducing sinus pressure |
gptkbp:is_often_depicted_as |
allergy relief products
cold and flu remedies sinus relief products |
gptkbp:is_part_of |
combination therapies
decongestant medications flu medications hay fever treatments multi-symptom cold medications |
gptkbp:is_subject_to |
purchase limits
|
gptkbp:is_used_by |
gptkb:Person
adults |
gptkbp:is_used_for |
relief of nasal congestion
|
gptkbp:is_used_in |
allergy medications
cold medications sinus medications |
gptkbp:material |
gptkb:drug
vasoconstrictor |
gptkbp:metabolism |
liver
|
gptkbp:operates_under |
various brand names
|
gptkbp:regulates |
Controlled Substances Act
|
gptkbp:side_effect |
dizziness
nausea insomnia increased heart rate |
gptkbp:suitable_for |
pregnant women
people with certain medical conditions nursing mothers children under 4 years old |
gptkbp:type_of |
570-68-1
|